EHA-SWG Scientific Meeting "the Blood and the Child - New Insights in Pediatric Benign Hematology"
Dates: April 7-9, 2022
Location: Rome, Italy
Chairs & collaborating EHA Scientific Working Groups:
Online registration is closed
Take the opportunity to learn from five different EHA Scientific Working Group representatives who will lead this comprehensive scientific meeting. During this three-day meeting, participants will focus on red blood cells and their diseases, iron metabolism defects, granulocyte and constitutional failure syndromes, thrombocytopenias and platelet function disorders, bleeding and thrombosis and transfusion medicine.
Below you can find key information and links to important details regarding registration and abstract submission.
The meeting platform is open and you can now access the platform if you registered for the meeting!
Hematologists, pediatricians, neonatologists, biologists and general practitioners.
Online registration is closed.
The meeting will be held at:
NH Collection Roma Vittorio Veneto
Corso d'Italia, 1, 00198 Roma RM, Italy
This meeting will cover the following topics:
- Bone marrow failures syndromes
- Hemopoietic stem cell transplantation
- Consultative pediatric hematology
- Red cell disorders
- Gene therapy and gene editing
- Bleeding and coagulation disorders
The complete program is available here.
Benign hematology consultations constitute a sizable proportion of the evaluation requests in traditional hematology/oncology practices. There is a need for physicians/pediatricians with adequate training, experience, interest, and expertise in assessing and treating patients with these disorders. Some hematologic issues are complex and require in-person histories and examinations, whereas others can be handled with advice electronically after a thorough chart review. To improve the quality of the care provided to these patients, the EHA-SWG Scientific Meeting “the Blood and the Child - New Insights in Pediatric Benign Hematology” was created. During this three-day meeting, participants will focus on red blood cells and its diseases, iron metabolism defects, granulocyte and constitutional failure syndromes, thrombocytopenias and platelet function disorders, bleeding and thrombosis and transfusion medicine.
Below you can find key information and links to important details regarding registration and accommodation. There is also a wide array of sponsorship opportunities available for pharmaceutical companies.
Abstract & case submission
Abstract and case submission is an important part of the EHA-SWG Scientific Meeting. As a participant, you have the opportunity to submit an abstract or clinical case for this meeting, and (if accepted) discuss it with a panel of international faculty and peers.
A selection of abstracts and clinical cases will be eligible for acceptance during the meeting, the presentation format will be in the form of oral presentations or poster presentations. Presenting authors will receive a separate invitation.
More information on the abstract and case submission can be found here
After attending this EHA-SWG Scientific Meeting, participants will be able to:
- diagnose benign inherited conditions of red cells, neutrophils, platelets and coagulation defects,
- treat the most relevant disorders in pediatric benign hematology,
- use of the new technologies for molecular defects identification, and
- improve their knowledge on how to diagnose and treat these inherited conditions during the pediatric age.
Continuing Medical Education (CME) is widely accepted to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field. The meeting will be accredited by the EBAH system. Participants of this meeting are eligible to receive one Continuing Medical Education (CME) credit point for every hour of accredited activity from the EBAH system.